3M Cavilon IV Site Brochure

3M™ Cavilon™ No Sting Barrier Film

Skin damage from adhesives at infusion sites can be a significant problem, particularly for those with fragile skin.

Frequent or repeated dressing changes can result in skin stripping injuries that compromise the epidermis or even more seriously, create a superficial wound. It is well documented that skin damage can lead to an increased risk of colonisation and infection.1,2 Local complications and certainly catheter-related blood stream infections (CRBSIs) are undesirable, resulting in negative clinical outcomes. In New Zealand, treatment costs for a CRBSI can cost between NZ$20,000 and NZ$54,000 per infection3, and in Australia the estimated annual cost is between AU$25.7 million and AU$95.3 million.4

Why is 3M Cavilon No Sting Barrier Film the ideal solution to protect skin around the infusion site?

Cavilon No Sting Barrier Film forms a breathable, transparent protective coating between the skin and the adhesive of the securement dressing, device or tape. When the dressing is changed, Cavilon No Sting Barrier Film is removed instead of skin cell layers.

Cavilon No Sting Barrier Film is like no other barrier film. The products unique 3M formulation contains a blend of not one but two polymers, including a Terpolymer and a Homopolymer (plasticizer). The Terpolymer is derived from three distinct monomers, that provides a protective coating on the skin creating a highly effective barrier. The Homopolymer enhances the films ability to flex with the skin and maintain a continuous, protective coating. Other barrier films contain only one polymer and some utilise alcohol as a solvent.

With Cavilon No Sting Barrier Film you can be confident that you have an effective barrier and excellent patient comfort.

TM

Skin Protection For I.V. Sites

Dressing and Securement Solutions 3M continues to deliver unique product solutions for I.V. securement that help make people’s lives better. Be sure to ask your 3M Skin & Wound Care Representative to see a sample of these breakthrough innovations, that include:

• 3M™ Tegaderm™ CHG Chlorhexidine Gluconate I.V. Securement Dressing

• 3M™ Tegaderm™ I.V. Advanced Securement Dressing

• 3M™ Kind Removal Silicone Tape

3M, Cavilon and Tegaderm are trademarks of 3M.Please recycle. © 3M 2013. All rights reserved.

Not all barrier films are created equal.Cavilon No Sting Barrier Film has 7 key characteristics that make it an intelligent choice for prevention of adhesive trauma at infusion sites:1. Proven to protect skin from adhesive trauma.5,6,7 3M has

over 70 pieces of clinical evidence supporting the efficacy and cost-effectiveness of Cavilon No Sting Barrier Film for multiple clinical uses, including prevention of adhesive trauma. This evidence collection is more comprehensive than any other barrier film. Refer to the Cavilon No Sting Barrier Film Clinical Evidence brochure.

2. Chlorhexidine Gluconate (CHG) Compatible.8 Using a non-CHG compatible barrier film could potentially interfere with the antimicrobial effectiveness of CHG. Tests have demonstrated that Cavilon No Sting Barrier Film does not react with CHG, so you can be assured that CHG effectiveness is not compromised by use of this unique barrier film.

3. Sterile.9 Helps maintain aseptic technique for the insertion and care of intravascular catheters – as per CDC Guidelines.14

4. Fast drying and non-sticky.10 For ease of use and patient comfort.

5. Non-cytotoxic.11 Will not interfere with healing if skin is damaged.6. Hypoallergenic.12

7. Non-stinging.13 Alcohol free and comfortable for use on damaged skin.

1. Wysocki AB. Anatomy and Physiology of Skin and Soft Tissue. In Bryant, RA and Nix DP eds. Acute and Chronic Wounds: Current Management Concepts. 4th ed. St Louis, MO: Elsevier Mosby; 2012: 40-62.

2. Roth,RR and James WD Microbial Ecology of the Skin. Annu. Rev. Microbiol. 1988; 42: 441-464.3. CMDHB Central Line Associated Bacteraemia How-to Guide. 2011 Ko Awatea, Counties.4. Bolz K et al. 2008. Management of central venous catheters in adult intensive care units in Australia:policies and practices, Healthcare Infection; 13; 48-55.5. Link, D. and Cutler,C. In search of a better central line dressing in the autologous bone marrow reinfusion patient. 1998. 3M White Paper.6. Campbell, K et al. A Clinical Evaluation of 3M™ Cavilon™ No Sting Barrier Film. Ostomy Wound Management. 2000; 46(1):24-30.7. Grove, GL et al. Comparison of the skin protection properties of various film forming skin protectants. Poster presentation at the Wound, Ostomy, and Continence Nurses Society Annual Conference. 1993.8-13. 3M Data on file14. Grady et al 2011, Guidelines for the Prevention of Intravascular Catheter Related Infections, Centers for Disease Control and Prevention, USA.

References

Skin & Wound Care Division3M New Zealand Limited94 Apollo Drive, Rosedale 0632Freephone 0800 80 81 82www.Cavilon.co.nz

Skin & Wound Care Division3M Australia Pty. LimitedABN 90 000 100 096Building A, 1 Rivett RoadNorth Ryde NSW 2113Phone 1300 363 878www.Cavilon.com.au

Australian Ordering InformationCatalog No. Product Size Items/Box Boxes/Case

3343 3M™ Cavilon™ No Sting Barrier FilmCovers a 15cm x 15cm area

1.0mL wand 25 4

3344E 3M™ Cavilon™ No Sting Barrier FilmCovers a 12.5cm x 12.5cm area

1.0mL wipe 30 6


3.0mL wand 25 4

New Zealand Ordering InformationCatalog No. Product Size Items/Box Boxes/Case


1.0mL wand 25 4

3344 3M™ Cavilon™ No Sting Barrier FilmCovers a 12.5cm x 12.5cm area

1.0mL wipe 25 4

Documents

3M Cavilon IV Site Brochure